Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study-Reference-Cited by-同舟云学术

Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study

Published:2018-10-15 Issue:1 Volume:40 Page:700-709
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Masajtis-Zagajewska Anna¹,Nowicki Michal¹

Affiliation:

1. Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, University Hospital and Teaching Center, Lodz, Poland

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/0886022X.2018.1535983

Reference44 articles.

1. Defining a renal anemia management period

2. New insights into the regulation of iron homeostasis

3. Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease

4. Hepcidin and iron regulation, 10 years later

5. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Statins on Serum Levels of TNF-alpha and Interleukin-6 in Patients with Kidney Disease: A Meta-analysis of Randomized Clinical Trials;Current Pharmaceutical Design;2024-06

2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

3. Development and validation of a prediction model for iron status in a large U.S. cohort of women;Scientific Reports;2023-10-12

4. Neutrophil-to-Serum Iron Ratio as a Promising Inflammatory Biomarker for Acute Myocardial Infarction and Gensini Score;Biomarkers in Medicine;2023-09

5. Problematic aspects of iron deficiency compensation in heart failure;Russian Journal of Cardiology;2023-03-20